Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Moderating job growth, rising inflation expectations and the prospect of reciprocal tariffs knocked the wind out of Wall ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

Supporters of the move believe USAID was poorly managed and wasting taxpayers' money, with White House Press Secretary ...

The North Asian private equity giant cited rising demand for semiconductor products amid the AI boom for its decision to ...

Korean Air anticipates uncertainties in the business environment this year due to shifts in the global political landscape, ...

Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...

A delay to US tariffs on goods from Mexico and Canada has done little to suggest Trump will change his course on trade levies ...

Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...

Companies across the country are bleeding cash as they struggle with overcapacity and weak spending in a slumping economy, ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China. The company disclosed preliminary results in mid January, but it left out important ...